Our Stroke portfolio delivers life-saving interventional solutions for patients with ischemic stroke for the best chance of a full recovery.
Our Vascular portfolio is transforming thrombectomy care for people suffering from devastating vascular diseases, including venous thromboembolism and acute limb ischemia.
We are developing the Telos robotic platform* to expand access to lifesaving care through purposeful design and innovation.
*Currently in development. Not approved for use or available for sale.
Imperative Care is addressing gaps across the entire patient journey to elevate care for patients suffering from stroke and other devastating vascular diseases.
Back to News
April 15, 2025
Imperative Care Announces Independent Randomized Clinical Trial for Treatment of M2 Occlusions in Stroke Patients
March 24, 2025
Imperative Care Expands Symphony Precision Thrombectomy Portfolio with Purpose-Built Design for the Treatment of Venous Thrombosis
January 27, 2025
Imperative Care Secures FDA 510(k) Clearance for the Zoom System, Including the First Large-Bore .088” Catheter for Aspiration When Used with the Zoom Catheters, for Stroke Treatment
Media Contact
Rigo Magana
Corporate Communications
rmagana@imperativecare.com
Investor Contact
Phil Nalbone
VP of Corporate Development and Investor Relations
pnalbone@imperativecare.com
Contact us
